Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.

Abigail L ThomsonAllyson C BerentChick W WeisseCatherine E Langston

Published in: Journal of veterinary internal medicine (2019)

Intra-arterial infusion of MSC into the renal artery in CKD cats was feasible and safe within a 3-month postoperative period. Efficacy and long-term safety have yet to be established. This procedure requires careful technique and training.

Keyphrases

chronic kidney disease
mesenchymal stem cells
clinical trial
end stage renal disease
low dose
bone marrow
cell therapy
patients undergoing
umbilical cord
stem cells
study protocol
minimally invasive
virtual reality
platelet rich plasma
peritoneal dialysis
double blind
replacement therapy